AMR Conference 2020

Save the date for the 4th AMR Conference on Novel Antimicrobials and AMR Diagnostics: 12–13 March 2020

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

See the 2019 conference highlights »

News in the AMR and antimicrobials space

Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents today: Gram-Negative...

Read more

HHS’s Biomedical Advanced Research and Development Authority, or BARDA, will provide up to $20.7 million over 2 years to VenatoRx Pharmaceuticals as...

Read more

Today, the Novo Holdings REPAIR Impact Fund announced a USD 5.25 million investment in Curza, a small-molecule therapeutics company based in Salt Lake...

Read more

We are proud to participate in the #GlobalAMRChallenge.

Learn more on the CDC website